Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$629M |
| 2 |
AGN
Allergan plc
AGN
|
+$463M |
| 3 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$350M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$315M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$978M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$675M |
| 3 |
Apple
AAPL
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$387M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.7% |
| 2 | Healthcare | 5.71% |
| 3 | Financials | 4.62% |
| 4 | Consumer Discretionary | 4.5% |
| 5 | Communication Services | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4051
Bally's
BALY
$686M
| $580K | ﹤0.01% |
25,426
+132
| +0.5% | +$3.25K |
|
|
BNY
4052
CALL
Bank of New York Mellon
BNY
$108B
| $579K | ﹤0.01% |
12,800
-16,800
| -57% | -$748K |
|
|
CDK
4053
CALL
DELISTED
CDK Global, Inc.
CDK
| $577K | ﹤0.01% |
12,000
+11,900
| +11,900% | +$570K |
|
|
XLRN
4054
CALL
DELISTED
Acceleron Pharma
XLRN
| $577K | ﹤0.01% |
14,600
| – | – |
|
4055
PUT
Allstate
ALL
$68.1B
| $576K | ﹤0.01% |
5,300
-1,800
| -25% | -$188K |
|
4056
PUT
Dana Inc
DAN
$3.01B
| $576K | ﹤0.01% |
39,900
+8,100
| +25% | +$126K |
|
|
BRY
4057
DELISTED
Berry Corp
BRY
| $573K | ﹤0.01% |
61,188
-877
| -1% | -$8.26K |
|
|
SEE
4058
PUT
DELISTED
Sealed Air
SEE
| $573K | ﹤0.01% |
13,800
+3,500
| +34% | +$148K |
|
4059
Hecla Mining
HL
$11.1B
| $572K | ﹤0.01% |
325,234
+4,126
| +1% | +$7.43K |
|
4060
Cohu
COHU
$2.45B
| $571K | ﹤0.01% |
42,291
-7,942
| -16% | -$110K |
|
4061
PUT
Marriott Vacations Worldwide
VAC
$3.49B
| $570K | ﹤0.01% |
5,500
-3,700
| -40% | -$364K |
|
4062
PUT
Dentsply Sirona
XRAY
$2.86B
| $570K | ﹤0.01% |
+10,700
| New | +$575K |
|
4063
Brown-Forman Class A
BF.A
$13.2B
| $568K | ﹤0.01% |
9,510
+8,888
| +1,429% | +$507K |
|
4064
CRISPR Therapeutics
CRSP
$5.07B
| $568K | ﹤0.01% |
13,877
+4,151
| +43% | +$198K |
|
4065
PUT
Itaú Unibanco
ITUB
$90.5B
| $568K | ﹤0.01% |
92,836
| – | – |
|
4066
Columbus McKinnon
CMCO
$621M
| $566K | ﹤0.01% |
15,520
-2,673
| -15% | -$99.2K |
|
4067
Equity Bancshares
EQBK
$1.06B
| $566K | ﹤0.01% |
21,096
-3,171
| -13% | -$83K |
|
4068
Veeco
VECO
$3.23B
| $565K | ﹤0.01% |
48,403
-7,719
| -14% | -$86.9K |
|
|
AMJ
4069
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
| $565K | ﹤0.01% |
+24,276
| New | +$586K |
|
4070
PUT
Myriad Genetics
MYGN
$301M
| $564K | ﹤0.01% |
19,700
-54,100
| -73% | -$1.58M |
|
|
HZNP
4071
PUT
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $564K | ﹤0.01% |
20,700
+14,400
| +229% | +$372K |
|
4072
Commercial Vehicle Group
CVGI
$154M
| $563K | ﹤0.01% |
78,139
+23,727
| +44% | +$174K |
|
4073
iShares MSCI Australia ETF
EWA
$1.44B
| $562K | ﹤0.01% |
25,258
+23,629
| +1,451% | +$522K |
|
4074
Algonquin Power & Utilities
AQN
$4.46B
| $559K | ﹤0.01% |
40,838
+512
| +1% | +$6.61K |
|
4075
PUT
Annaly Capital Management
NLY
$17.1B
| $559K | ﹤0.01% |
15,875
+2,400
| +18% | +$86.5K |
|
Similar funds
Barclays's Q3 2019 Portfolio in Review
As of Q3 2019, Barclays held 7,551 positions worth $160B, down 2.1% from $163B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays's Q3 2019 filing shows 501 new, 2,626 increased, 3,452 reduced and 568 closed positions. Its largest new stake was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $978M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2019 buy was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M.
- Barclays added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019, an estimated $629M increase.
- Barclays's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $978M.
- Barclays fully exited Anadarko Petroleum in Q3 2019, selling an estimated $309M.
- Barclays's ten largest holdings make up 28% of its $160B portfolio in Q3 2019.
- Barclays opened 501 new positions and closed 568 in Q3 2019.
- Barclays's portfolio value fell 2.1% quarter-over-quarter to $160B.
Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.